296
Participants
Start Date
December 17, 2017
Primary Completion Date
November 25, 2018
Study Completion Date
December 25, 2018
Nerivio Migra-1 active device
"The device is placed on the subject upper arm. when activated, stimulus is applied to influence the subject's perception of a painful stimulus, delivered (or originating) at a different location. Based on diffused noxious inhibitory control mechanism, sometimes referred to as pain inhibits pain principle, conditioned pain modulation evokes an endogenous analgesic mechanism. The modulatory effect is over the whole body, and can be induced anywhere in the body. This approach allows applying the conditioning stimuli away from the painful site."
Nerivio Migra-1 Sham device
The device is placed on the subject upper arm. when activated, the stimulus is applied is not sufficient to influence the subject's perception of a painful stimulus.
Northwell Health, Inc, New York
Rochester Clinical Research, Rochester
Thomas Jefferson University, Philadelphia
wolfson Medical Center, Holon
Mercy Hospital, St Louis
Clinvest Research, Springfield
Clinical Reseach Consortium, Las Vegas
Meir Medical Center, Kfar Saba
Belinson Medical Center, Petah Tikva
Hartford Headache Center, Hartford
Rambam Medical Center, Haifa
Souraskyr Medical center - Ichilov, Tel Aviv
Lead Sponsor
Collaborators (1)
Rambam Health Care Campus
OTHER
Northwell Health
OTHER
Theranica
INDUSTRY